PAOG Expects To Report First Post Acquisition Revenue In Q4 2020

Sandusky, OH, December 22, 2020 – -- PAO Group, Inc. (OTC PINK: PAOG) today announced that the company expects to realize and report in Q3 2020 the first revenue from assets acquired in the course of 2020. In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC PINK: PURA) and RespRx from Kali-Extracts, Inc. (OTC PINK: KALY) RespRx is a cannabis treatment under development for COPD derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled...

read more

PAOG Announces Puerto Rico Consortium For Clinical Investigation Engagement To Advance CBD COPD Nutraceutical Care Solution

  Sandusky, OH, December 17, 2020 – -- PAO Group, Inc. (OTC US: PAOG) today announced an engagement with the Puerto Rico Consortium for Clinical Investigation to assist PAOG with developing its proprietary Cannabidiol (CBD) extract into a nutraceutical product to provide care for those experiencing issues associated with Chronic Obstructive Pulmonary Disorder (COPD).     On July 30, 2020, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC US: KALY) RespRx is a cannabis treatment...

read more


Mcap MediaWire - Costumer Service

Translate »